Meckler Jeffrey A's Form 4 filing
Indaptus Therapeutics, Inc. (INDP) · filed Sep 8, 2022
- Accession no.
- 0001493152-22-025319
- Filed
- Sep 8, 2022
- Trade date
- Sep 6-7, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $24.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Meckler Jeffrey ACIK 0001506916 | Director, Officer (CEO and Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2022 | Common stock | PPurchaseAcquired | +1,060 | $2.44 | +$2,586.4 | 46,434 | Direct | |
| Sep 7, 2022 | Common stock | PPurchaseAcquired | +8,632 | $2.57 | +$22,184.24 | 55,066 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.